Sacroiliac Joint Fusion Injections And RF Ablation Market Size, Share & Trends Analysis Report By Indication (Degenerative Sacroiliitis, Sacral Disruption), By Type (Diagnosis), By End-use, By Region, And Segment Forecasts, 2024 - 2030

Sacroiliac Joint Fusion Injections And RF Ablation Market Size, Share & Trends Analysis Report By Indication (Degenerative Sacroiliitis, Sacral Disruption), By Type (Diagnosis), By End-use, By Region, And Segment Forecasts, 2024 - 2030


Sacroiliac Joint Fusion Injections and RF Ablation Market Growth & Trends

The global sacroiliac joint fusion injections and RF ablation market size is expected to reach USD 1.51 billion by 2030, expanding at a CAGR of 20.2% from 2024 to 2030, according to a new study by Grand View Research, Inc. Key market players are investing substantially in research & development (R&D) activities to create innovative and effective devices. This increase in R&D activities is expected to drive market growth over the coming years. In addition, the market is expected to grow further due to the increasing prevalence of bone disorders and ongoing technological advancements.

Increasing prevalence of lower back, buttock, groin, and lower extremity pain drives SI joint fusion market growth. These chronic and debilitating forms of pain have become alarmingly common, affecting a substantial portion of the global population. This trend poses significant challenges to healthcare systems and fuels demand for innovative solutions to alleviate suffering and restore mobility. According to the National Center for Biotechnology Information (NCBI) study published in December 2023, approximately 23% of adults globally experience chronic low back pain, and the recurrence rate within a year range from 24% to 80%. The lifetime back pain prevalence in adults reaches as high as 84%.

Sacroiliac Joint Fusion Injections and RF Ablation Market Report Highlights
  • Based on indication, thedegenerative sacroilitis segment accounted for the largest revenue share in 2023 and is anticipated to grow at the fastest CAGR. The growth is attributed to the growing awareness about the condition, improving diagnostic capabilities for sacroiliac joint disorders, and a high prevalence of degenerative sacroiliitis
  • Based on type, the diagnosis segment accounted for the largest market share in 2023. The growth is attributed to the accurate diagnosis and determining the appropriate treatment for sacroiliac joint pain
  • Based on end-use, the hospitals segment accounted for the largest revenue share in 2023 owing to the higher volume of surgeries performed in hospitals and a growing preference for minimally invasive surgeries
  • In 2023, North America dominated the overall market with a revenue share of 41.1% owing to advanced healthcare infrastructure, the presence of key companies, and growing reimbursement coverage
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Indication
1.2.2. Type
1.2.3. End-use
1.2.4. Regional Scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Indication outlook
2.2.2. Type outlook
2.2.3. End Use outlook
2.3. Regional outlook
2.4. Competitive Insights
Chapter 3. Sacroiliac Joint Fusion Injections and RF Ablation Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Sacroiliac Joint Fusion Injections and RF Ablation Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
Chapter 4. Sacroiliac Joint Fusion Injections and RF Ablation Market: Indication Estimates & Trend Analysis
4.1. Indication Segment Dashboard
4.2. Sacroiliac Joint Fusion Injections and RF Ablation Market: Indication Movement Analysis
4.3. Sacroiliac Joint Fusion Injections and RF Ablation Market by Indication Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Degenerative Sacroilitis
4.5.1. Degenerative Sacroilitis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Sacral Disruption
4.6.1. Sacral Disruption Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Trauma
4.7.1. Trauma Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Sacroiliac Joint Fusion Injections and RF Ablation Market: Type Estimates & Trend Analysis
5.1. Type Segment Dashboard
5.2. Sacroiliac Joint Fusion Injections and RF Ablation Market: Type Movement Analysis
5.3. Sacroiliac Joint Fusion Injections and RF Ablation Market by Type Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Diagnosis
5.5.1. Diagnosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Treatment
5.6.1. Treatment Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Sacroiliac Joint Fusion Injections and RF Ablation Market: End-use Estimates & Trend Analysis
6.1. End-use Segment Dashboard
6.2. Sacroiliac Joint Fusion Injections and RF Ablation Market: End-use Movement Analysis
6.3. Sacroiliac Joint Fusion Injections and RF Ablation Market by End-use Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. Hospitals
6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Ambulatory Surgical Centers
6.6.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Others
6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Sacroiliac Joint Fusion Injections and RF Ablation Market: Regional Estimates & Trend Analysis
7.1. Regional Dashboard
7.2. Regional Sacroiliac Joint Fusion Injections and RF Ablation Market Movement analysis
7.3. Sacroiliac Joint Fusion Injections and RF Ablation Market: Regional Estimates & Trend Analysis by Indication, Type & End-use
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5. North America
7.5.1. North America Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. U.S.
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. U.S. Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Mexico Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.4. Canada
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. Canada Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.5. Europe
7.5.6. Europe Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.7. UK
7.5.7.1. Key Country Dynamics
7.5.7.2. Competitive Scenario
7.5.7.3. Regulatory Framework
7.5.7.4. UK Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.8. Germany
7.5.8.1. Key Country Dynamics
7.5.8.2. Competitive Scenario
7.5.8.3. Regulatory Framework
7.5.8.4. Germany Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.9. France
7.5.9.1. Key Country Dynamics
7.5.9.2. Competitive Scenario
7.5.9.3. Regulatory Framework
7.5.9.4. France Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.10. Italy
7.5.10.1. Key Country Dynamics
7.5.10.2. Competitive Scenario
7.5.10.3. Regulatory Framework
7.5.10.4. Italy Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.11. Spain
7.5.11.1. Key Country Dynamics
7.5.11.2. Competitive Scenario
7.5.11.3. Regulatory Framework
7.5.11.4. Spain Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.12. Denmark
7.5.12.1. Key Country Dynamics
7.5.12.2. Competitive Scenario
7.5.12.3. Regulatory Framework
7.5.12.4. Denmark Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.13. Sweden
7.5.13.1. Key Country Dynamics
7.5.13.2. Competitive Scenario
7.5.13.3. Regulatory Framework
7.5.13.4. Sweden Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.14. Norway
7.5.14.1. Key Country Dynamics
7.5.14.2. Competitive Scenario
7.5.14.3. Regulatory Framework
7.5.14.4. Norway Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Japan Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. China Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. India Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. South Korea
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. South Korea Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.6. Australia
7.6.6.1. Key Country Dynamics
7.6.6.2. Competitive Scenario
7.6.6.3. Regulatory Framework
7.6.6.4. Australia Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.7. Thailand
7.6.7.1. Key Country Dynamics
7.6.7.2. Competitive Scenario
7.6.7.3. Regulatory Framework
7.6.7.4. Thailand Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Latin America
7.7.1. Latin America Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. Brazil Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. Argentina Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. Middle East & Africa
7.8.1. Middle East & Africa Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. Regulatory Framework
7.8.2.4. South Africa Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Regulatory Framework
7.8.3.4. Saudi Arabia Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Competitive Scenario
7.8.4.3. Regulatory Framework
7.8.4.4. UAE Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Competitive Scenario
7.8.5.3. Regulatory Framework
7.8.5.4. Kuwait Sacroiliac Joint Fusion Injections and RF Ablation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Key Company Profiles
8.2.1. SI-BONE, Inc.
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. PainTEQ
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. CornerLoc
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. SIGNUS Medizintechnik GmbH
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Globus Medical
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Orthofix Medical, Inc.
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. Life Spine, Inc.
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Camber Spine Technologies, LLC
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. CoreLink Surgical
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. Xtant Medical
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives
8.2.11. Surgalign Spine Technologies, Inc.
8.2.11.1. Company overview
8.2.11.2. Financial performance
8.2.11.3. Product benchmarking
8.2.11.4. Strategic initiatives
8.2.12. Medtronic
8.2.12.1. Company overview
8.2.12.2. Financial performance
8.2.12.3. Product benchmarking
8.2.12.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings